Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
The outbreak of SARS-CoV-2 infection has enormously impacted our lives. Clinical evidence has implicated the emergence of cytokine release syndrome as the prominent cause of mortality in COVID-19 patients.
Guardado en:
Autores principales: | Najmeh Bozorgmehr, Siavash Mashhouri, Eliana Perez Rosero, Lai Xu, Shima Shahbaz, Wendy Sligl, Mohammed Osman, Demetrios J. Kutsogiannis, Erika MacIntyre, Conar R. O’Neil, Shokrollah Elahi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b84f3e8f207047368318863214003125 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection.
por: Garett Dunsmore, et al.
Publicado: (2021) -
Differential Signature of the Microbiome and Neutrophils in the Oral Cavity of HIV-Infected Individuals
por: Eliana Perez Rosero, et al.
Publicado: (2021) -
CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis
por: Afshin Namdar, et al.
Publicado: (2017) -
CD71<sup>+</sup> Erythroid Cells Exacerbate HIV-1 Susceptibility, Mediate <italic toggle="yes">trans</italic>-Infection, and Harbor Infective Viral Particles
por: Afshin Namdar, et al.
Publicado: (2019) -
Does Diabetes Alter Immunolocalization of Galectin-1 and Galectin-3 in the Rat Ovary?
por: Özdenoglu,Berna, et al.
Publicado: (2016)